Skip to content

A Pichia pastoris-based platform for large-scale production of functional recombinant human serum albumin with therapeutic efficacy

Jul 2026 · Bioprocess and biosystems engineering (Print) · Vol 49, pp. 2213 - 2223 · 0 citations · 36 references
Medicine

TL;DR

This study provides the first in vivo evidence confirming the therapeutic equivalence and dose-effect relationship of P. pastoris-derived rHSA compared with pHSA, supporting its potential as a viable clinical substitute for plasma-derived albumin.

View source

Similar papers

Oct 2026

B-017 A Purified Recombinant Human Albumin Produced in Thermothelomyces heterothallica (C1) Better Mimics Native Human Serum Albumin than Recombinant Albumin from Other Expression Systems

It is demonstrated that rHA produced in Thermothelomyces heterothallica (C1) more closely mimics native HSA than recombinant albumins produced in yeast and plant expression systems.

Audrianna Kern, Garry Smith, A. Okerlund et al. · 0 citations
Open access Sep 2026

Ogataea Yeast Platform for Recombinant Porcine Interferon-Alpha 1 Production: Toward Alternative Biotherapeutics for Swine Health Management

Based on the proof-of-concept results in this study, the OP39 platform can be further developed into a viable, full freedom-to-operate system for local or regional biomanufacturing of biologically active veterinary therapeutics to support livestock health management.

Benjamas Liwnaree, Thorntun Deangphare, C. Assana et al. · 0 citations
Aug 2026

Preperation of an engineered tryptophan-depleted protein in Pichia pastoris and evaluation of its dietary anti-tumor efficacy.

A novel tryptophan-depleted protein (TDP) is developed through protein engineering combined with the Pichia pastoris expression system, for dietary intervention to suppress tumor growth in vivo and establishes a novel strategic framework for dietary intervention in adjuvant cancer therapy.

Huijia Dai, Yuluo Chen, Ya-Ying Xie et al. · 0 citations
Oct 2026

B-168 Purified Recombinant Human Albumin Produced in Thermothelomyces heterothallica (C1) Demonstrates Effective Blocking and Comparable Surface Binding to Other Recombinant and Native Albumins

Findings support C1-derived rHA as a reliable alternative for surface blocking and coating applications, offering comparable performance while reducing variability and production cost limitations associated with existing albumin products.

Audrianna Kern, A. Okerlund, C. Kunkler et al. · 0 citations
#protein folding Oct 2026

Efficient production of recombinant human serum albumin in Escherichia coli via oxidative folding mediated by the a domain of protein disulfide isomerase.

It is demonstrated that PDI(a)-mediated cis-fusion enables high-yield production of structurally native-like and functionally competent HSA in the bacterial cytosol and provides a practical platform for producing complex disulfide-rich proteins in E. coli.

R. Urade, Yuki Yamaguchi, K. Morishima et al. · 0 citations
Sep 2026

Harnessing Yarrowia lipolytica as a platform for animal-free and secretory production of human lactoferrin.

Y. lipolytica is developed as a microbial platform for high-level production and secretion of recombinant hLF and established as a promising platform for sustainable, animal-free manufacturing of lactoferrin and potentially other high-value nutritional and therapeutic proteins.

Zi-Zhao Wu, Hong-Chao Ren, Pei-Yan Cai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.